American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 965-969 , November 2009

A 42-Year-Old Woman With Flaccid Paralysis

  • Thomas D. DuBose Jr, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Thomas D. DuBose Jr, MD, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1052

Received 16 April 2009 ,Accepted 7 July 2009.

References 

  1. DuBose TD. Disorders of acid-base balance. In:  Brenner B editors. Brenner & Rector's The Kidney. (ed 6). Philadelphia, PA: Saunders; 2008;p. 505–546
  2. Simpson AG, Schwartz GJ. Distal renal tubular acidosis with severe hypokalaemia, probably caused by colonic H+-K+-ATPase deficiency. Arch Dis Child. 2001;84:504–507
  3. Poux JM, Peyronnet P, Le Meur Y, et al. Hypokalemic quadriplegia and respiratory arrest revealing primary Sjögren syndrome. Clin Nephrol. 1992;37:189–191
  4. Cohen EP, Bastani B, Cohen MR, et al. Absence of H+-ATPase in cortical collecting tubules of a patient with Sjögren syndrome and distal renal tubular acidosis. J Am Soc Nephrol. 1992;3:264–271
  5. Bae EH, Han CW, Lee JH, et al. Hypokalemia associated with nephrocalcinosis. Kidney Int. 2009;75:443–444
  6. Takemoto F, Hoshino J, Sawa N, et al. Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjögren syndrome. Am J Med. 2005;118:181–184
  7. Takemoto F, Katori H, Sawa N, et al. Induction of anti-carbonic-anhydrase-II antibody causes renal tubular acidosis in a mouse model of Sjögren syndrome. Nephron Physiol. 2007;106:63–68
  8. DuBose TD, Lucci MS. Effect of carbonic anhydrase inhibition on superficial and deep nephron bicarbonate reabsorption in the rat. J Clin Invest. 1983;71:55–65
  9. Routsias JG, Tzioufas AG. Sjögren syndrome—study of autoantigens and autoantibodies. Clin Rev Allergy Immunol. 2007;32:238–251
  10. DuBose TD, McDonald GA. Renal tubular acidosis. In:  DuBose TD,  Hamm L editor. Acid-Base and Electrolyte Disorders: A Companion to Brenner and Rector's The Kidney. Philadelphia, PA: Saunders; 2002;p. 189–206
  11. Pertovaara M, Korpela M, Pasternack A. Factors predictive of renal involvement in patients with primary Sjögren syndrome. Clin Nephrol. 2001;56:10–18
  12. Pijpe J, van Imhoff GW, Spijkervet FK, et al. Rituximab treatment in patients with primary Sjögren syndrome: an open-label phase II study. Arthritis Rheum. 2005;52:2740–2750

 Originally published online as doi: 10.1053/j.ajkd.2009.07.006 on September 27, 2009.

PII: S0272-6386(09)00980-9

doi: 10.1053/j.ajkd.2009.07.006

American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 965-969 , November 2009

Article Tools

* Image Usage & Resolution